What XBiotech Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Mckenzie W Thorpe | Director | Dec 16 | Withheld — tax / exercise cost · F | −213,493 | $11.71 | −$2.5M | 2,597,471 |
| Mckenzie W Thorpe | Director | Dec 16 | Exercise / conversion · M | +250,000 | $10.00 | +$2.5M | 2,810,964 |
| Simard John | Chief Executive Officer | Oct 18 | Open-market sale · S | −33,000 | $13.07 | −$431K | 3,823,166 |
| Simard John | Chief Executive Officer | Oct 15 | Open-market sale · S | −17,000 | $13.32 | −$226K | 3,856,166 |
| Simard John | Chief Executive Officer | Oct 14 | Open-market sale · S | −21,125 | $12.90 | −$273K | 3,873,166 |
| Simard John | Chief Executive Officer | Oct 13 | Open-market sale · S | −10,875 | $12.83 | −$140K | 3,962,452 |
| Simard John | Chief Executive Officer | Oct 12 | Open-market sale · S | −18,000 | $12.77 | −$230K | 3,973,166 |
| Simard John | Chief Executive Officer | Oct 07 | Open-market sale · S | −39,286 | $12.45 | −$489K | 3,923,166 |
| Simard John | Chief Executive Officer | Oct 06 | Open-market sale · S | −10,714 | $12.53 | −$134K | 3,962,452 |
| Simard John | Chief Executive Officer | Oct 05 | Open-market sale · S | −14,218 | $12.66 | −$180K | 3,973,166 |
| Simard John | Chief Executive Officer | Oct 04 | Open-market sale · S | −23,681 | $13.08 | −$310K | 3,987,384 |
| Simard John | Chief Executive Officer | Oct 01 | Open-market sale · S | −19,684 | $13.23 | −$260K | 4,011,065 |
| Simard John | Chief Executive Officer | Sep 30 | Open-market sale · S | −18,558 | $13.07 | −$242K | 4,030,749 |
| Simard John | Chief Executive Officer | Sep 29 | Open-market sale · S | −16,396 | $13.41 | −$220K | 4,049,307 |
| Simard John | Chief Executive Officer | Sep 28 | Open-market sale · S | −6,263 | $14.27 | −$89.4K | 4,065,703 |
| Simard John | Chief Executive Officer | Sep 27 | Open-market sale · S | −29,890 | $14.81 | −$443K | 4,071,966 |
| Simard John | Chief Executive Officer | Sep 24 | Open-market sale · S | −11,418 | $14.49 | −$165K | 4,101,856 |
| Simard John | Chief Executive Officer | Sep 23 | Open-market sale · S | −9,892 | $14.68 | −$145K | 4,113,274 |
| Simard John | Chief Executive Officer | Sep 22 | Open-market sale · S | −19,669 | $15.14 | −$298K | 4,123,166 |
| Simard John | Chief Executive Officer | Sep 21 | Open-market sale · S | −16,860 | $15.24 | −$257K | 4,142,835 |
Loading...